CURRENT DEVELOPMENTS AND PERSPECTIVES IN MULTIPLE MYELOMA

by Michel Delforge, Stefan Knop, Mohamad Mohty
Published 2014-07-01

Two Cases of Heavy Chain MGUS

by Jan Van Keer, Björn Meijers, Michel Delforge, Gregor Verhoef, Koen Poesen
Published 2016-01-01

Renal Thrombotic Microangiopathy Associated with the Use of Bortezomib in a Patient with Multiple Myeloma

by Jan Van Keer, Michel Delforge, Daan Dierickx, Kathelijne Peerlinck, Evelyne Lerut, Ben Sprangers
Published 2016-01-01

Comparison of 2 Serum-Free Light-Chain Assays in CKD Patients

by Ben Sprangers, Kathleen Claes, Pieter Evenepoel, Dirk Kuypers, Koen Poesen, Michel Delforge, Xavier Bossuyt V, Björn Meijers
Published 2020-05-01

Novel risk stratification algorithm for estimating the risk of death in patients with relapsed multiple myeloma: external validation in a retrospective chart review

by Roman Hájek, Sebastian Gonzalez-McQuire, Zsolt Szabo, Michel Delforge, Lucy DeCosta, Marc S Raab, Walter Bouwmeester, Marco Campioni, Andrew Briggs
Published 2020-07-01

A double-edged sword

by Martijn Vandebotermet, Frederik Staels, Simone Giovannozzi, Michel Delforge, Thomas Tousseyn, Thomas Steelandt, Anniek Corveleyn, Isabelle Meyts, Johan Maertens, Jonas Yserbyt, Rik Schrijvers
Published 2020-09-01

Target identification of small molecules using large-scale CRISPR-Cas mutagenesis scanning of essential genes

by Jasper Edgar Neggers, Bert Kwanten, Tim Dierckx, Hiroki Noguchi, Arnout Voet, Lotte Bral, Kristien Minner, Bob Massant, Nicolas Kint, Michel Delforge, Thomas Vercruysse, Erkan Baloglu, William Senapedis, Maarten Jacquemyn, Dirk Daelemans
Published 2018-02-01

Multiple Myeloma: EHA-ESMO Clinical Practice Guidelines for Diagnosis, Treatment and Follow-up

by Meletios A. Dimopoulos, Philippe Moreau, Evangelos Terpos, María-Victoria Mateos, Sonja Zweegman, Gordon Cook, Michel Delforge, Roman Hájek, Fredrik Schjesvold, Michele Cavo, Hartmut Goldschmidt, Thierry Facon, Hermann Einsele, Mario Boccadoro, Jesús San-Miguel, Pieter Sonneveld, Ulrich Mey, on behalf of the EHA Guidelines Committee and the ESMO Guidelines Committee
Published 2021-02-01

Patient Preferences for Multiple Myeloma Treatments: A Multinational Qualitative Study

by Rosanne Janssens, Tamika Lang, Ana Vallejo, Jayne Galinsky, Ananda Plate, Kate Morgan, Elena Cabezudo, Raija Silvennoinen, Raija Silvennoinen, Daniel Coriu, Daniel Coriu, Sorina Badelita, Ruxandra Irimia, Ruxandra Irimia, Minna Anttonen, Riikka-Leena Manninen, Elise Schoefs, Martina Vandebroek, Anneleen Vanhellemont, Michel Delforge, Hilde Stevens, Steven Simoens, Isabelle Huys
Published 2021-07-01

Insights on Multiple Myeloma Treatment Strategies

by María-Victoria Mateos, Heinz Ludwig, Ali Bazarbachi, Meral Beksac, Joan Bladé, Mario Boccadoro, Michele Cavo, Michel Delforge, Meletios A. Dimopoulos, Thierry Facon, Catarina Geraldes, Hartmut Goldschmidt, Roman Hájek, Markus Hansson, Krzysztof Jamroziak, Merav Leiba, Tamás Masszi, Larisa Mendeleeva, Michael O’Dwyer, Torben Plesner, Jesús F. San-Miguel, Christian Straka, Niels W.C.J. van de Donk, Kwee Yong, Samo Zver, Philippe Moreau, Pieter Sonneveld
Published 2019-02-01

Quality of life analyses in patients with multiple myeloma: results from the Selinexor (KPT-330) Treatment of Refractory Myeloma (STORM) phase 2b study

by Gabriel Tremblay, Patrick Daniele, Janis Breeze, Lingling Li, Jatin Shah, Sharon Shacham, Michael Kauffman, Monika Engelhardt, Ajaj Chari, Ajay Nooka, Dan Vogl, Maria Gavriatopoulou, Meletios-Athanasios Dimopoulos, Paul Richardson, Noa Biran, David Siegel, Philip Vlummens, Chantal Doyen, Thierry Facon, Mohamad Mohty, Nathalie Meuleman, Moshe Levy, Luciano Costa, James E. Hoffman, Michel Delforge, David Kaminetzky, Katja Weisel, Marc Raab, David Dingli, Sascha Tuchman, Frenzel Laurent, Ravi Vij, Gary Schiller, Philippe Moreau, Joshua Richter, Martin Schreder, Klaus Podar, Terri Parker, Robert Frank Cornell, Karlin Lionel, Sylvain Choquet, Jagannath Sundar
Published 2021-09-01